|Day Low/High||2.35 / 2.58|
|52 Wk Low/High||2.03 / 19.60|
When there is no real worry, stocks can keep on running, but the rampage in the Nasdaq 100 is not unlike frothy action of the past.
Strategic Move to Attract a Broader Range of Investors, to Ensure a Strong Balance Sheet, and to Enable the Expansion of the Company's Product Pipeline
Company to Hold Conference Call on Friday, May 12, 2017 at 11:00 a.m. ET
Patients in First Four Cohorts Show Clinically Meaningful Responses in the Evaluation of GEN-1, A Novel IL-12 DNA-based Immunotherapy, in Combination with the Standard of Care
Study's Lead Investigator to Report Updated Translational Research Data
Company to Hold Conference Call on Thursday, March 16, 2017 at 11:00 a.m. ET
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
Strengthens Global Patent Portfolio Around Novel Heat-Sensitive Liposome Engineered to Address a Broad Range of Difficult-to-Treat Cancers
Study to Complete Final Patient Cohort as Planned
Strengthens Patent Portfolio around Innovative GEN-1 IL-12 Immunotherapy for the Treatment of Cancer and Hyperproliferative Diseases
Supportive Data for the Phase III OPTIMA Study Demonstrates the Potential for a 2 Year Overall Survival Benefit